Oramed Pharmaceuticals Cash Flow Statement (2010-2026) | ORMP

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	May2021	Aug2021	Nov2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)		-22.99M		-11.25M	-11.42M	-7.25M	-12.26M	-5.21M	-1.31M	-3.28M	13.30M	1.53M	9.20M	-19.64M	-10.20M	-7.64M	13.26M	48.39M	10.01M	38.31M
Depreciation and Depletion (Quarter)	0.03M	0.07M	0.01M	0.01M	0.01M	0.01M	0.02M	0.04M	0.05M	0.05M	0.05M	0.06M	0.05M	0.05M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M
Share-based Compensation (Quarter)	0.98M	2.66M	1.71M	4.03M	1.88M	3.05M	-8.94M	0.17M	1.82M	-1.98M	4.20M	1.29M	1.23M	0.30M	1.23M	2.19M	0.80M	0.72M	2.28M	1.74M
Deferred Taxes (Quarter)																		-7.69M	0.01M	-9.84M
Gains from Sales and Divestitures (Quarter)		0.24M					0.00M				0.52M				0.93M				1.88M
Gains from Investment Securities (Quarter)		0.01M		0.68M		0.11M	1.92M	-0.07M	-0.76M	0.09M	-16.20M	-3.75M	0.09M	0.09M	7.55M	0.29M	1.02M	1.02M	-0.20M	1.52M
Asset Writedowns and Impairment (Quarter)
Non-cash Items (Quarter)		0.86M					0.05M				1.48M			4.00M	1.44M				5.04M
Cash from Operations (Quarter)	-5.64M	-11.20M	-6.90M	-9.12M	-8.49M	-2.24M	-8.06M	-5.55M	-2.63M	-0.69M	-1.42M	-1.48M	2.08M	-7.10M	-1.91M	-3.52M	-3.54M	-1.62M	-0.47M	-2.92M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)	0.03M	0.07M	0.01M	0.01M	0.01M	0.01M	0.02M	0.04M	0.05M	0.05M	0.05M	0.06M	0.05M	0.05M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M
Change in Working Capital
Change in Account Payables (Quarter)								-0.10M	-3.23M	1.73M	-0.62M	-0.67M	2.21M	1.55M
Change in Accured Expenses (Quarter)	-0.02M	0.08M	-0.00M		-0.04M	0.04M		0.01M	0.00M		0.00M	-0.67M	0.66M	3.10M	-3.11M	-0.18M	0.12M	0.07M	-0.07M	0.00M
Other Working Capital Changes (Quarter)	-0.68M	-2.13M	0.60M	-0.67M	-0.67M	0.31M	0.33M	-0.00M	-1.34M	0.61M	0.73M	-0.04M	0.03M	0.03M	0.33M	-0.67M	-1.33M		3.00M	-0.43M
Investing Activities
Capital Expenditures (Quarter)	0.00M	0.37M		0.05M	0.02M	0.12M	0.31M	0.20M	0.02M	0.03M	0.00M	0.00M		0.01M	0.01M	0.00M	0.00M		0.00M	0.01M
Divestments (Quarter)																2.74M	0.71M	2.81M
Change in Acquisitions & Divestments (Quarter)	15.96M	10.47M	0.95M	2.41M	1.38M	124.21M	50.20M	4.50M	-1.77M	0.65M	1.62M	15.00M	78.65M	-56.65M	27.50M	0.88M	0.17M	49.40M	-10.88M	2.78M
Cash from Investing Activities (Quarter)	7.39M	-17.43M	-99.05M	7.36M	10.36M	1.23M	11.26M	-13.20M	-14.71M	-75.12M	30.00M	30.00M	94.66M	-34.26M	15.42M	23.62M	-54.85M	38.36M	-1.68M	-19.49M
Financing Activities
Other financing activities (Quarter)				-0.68M		0.11M	-7.99M	-0.12M	-1.77M	-0.80M	6.74M	1.28M	1.21M	0.29M	1.22M	2.19M	0.80M	0.72M	2.28M	1.74M
Cash from Financing Activities (Quarter)	21.86M	80.58M	60.56M	2.29M	-0.00M	4.31M	4.17M	2.43M		74.55M	-25.00M	-19.00M	-30.55M	-1.29M	-1.20M			-0.36M	-4.01M	-10.36M
Dividend Payments
Dividends Paid - Common (Quarter)																				10.36M
Additional items
Exchange Rate Effect (Quarter)	-0.00M	-0.00M	0.02M		0.01M	0.00M	-0.10M	-0.04M	0.01M	-0.03M	0.01M	-0.00M	-0.00M	0.00M	-0.00M	-0.00M	0.04M	0.00M	-0.07M	0.02M
Change in Cash (Quarter)	23.61M	51.97M	-45.37M	0.51M	1.93M	3.30M	7.27M	-16.36M	-17.34M	-1.30M	3.59M	9.52M	66.18M	-42.65M	12.32M	20.10M	-58.72M	36.38M	-6.23M	-32.74M
Free Cash Flow (Quarter)	-5.64M	-11.57M	-6.90M	-9.17M	-8.51M	-2.36M	-8.37M	-5.75M	-2.65M	-0.73M	-1.42M	-1.48M	2.08M	-7.11M	-1.92M	-3.52M	-3.54M	-1.62M	-0.47M	-2.92M
Net Cash Flow (Quarter)	23.61M	51.96M	-45.39M	0.53M	1.87M	3.30M	7.37M	-16.32M	-17.34M	-1.27M	3.58M	9.52M	66.18M	-42.65M	12.32M	20.10M	-58.39M	36.38M	-6.16M	-32.77M

Research Tools

Developers

Oramed Pharmaceuticals Cash Flow Statement (2010-2026) | ORMP

Research Tools

Developers

Oramed Pharmaceuticals Cash Flow Statement (2010-2026) | ORMP

Create an account

Sign In

Reset Password